Therachon Company
Therachon is a global biotechnology company focused on developing medicines for rare, genetic diseases that currently have no available treatments. The company’s lead pipeline candidate, TA-46, is a novel protein therapy in development for achondroplasia, the most common form of short-limbed dwarfism. Therachon is headquartered in Basel, Switzerland, with research labs in Nice, France.
Invests into
Headquarters:
Basel, Basel-Stadt, Switzerland, Europe
Employee Number:
1-10
Industry:
Drug Discovery & Development
Founded Date:
2014-01-01
Super Industry:
Biopharma & Life Science Tools
Phone Number:
+41798989209
Investors:
Bpifrance, New Enterprise Associates, Novo Holdings, OrbiMed, Versant Ventures
Ipo Status:
private
City:
Basel
Region:
Basel-Stadt
Country:
Switzerland
Founders:
Elvire Gouze, Luca Santarelli










